Investing Profile

Nina Kjellson

VCInvestor

General Partner at Canaan Partners

Your Intro Paths to Nina Kjellson

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Nina Kjellson on

Current Investing Position

Canaan Partners General Partner

Investment Range

$250K - $20.0M

Sweet Spot

$10.0M

Investments On Record

Current Fund Size

$800M

Nina Kjellson is on these Sector & Stage Rankings

Nina Kjellson's Investments On Record (19)

Company	StageDateRound Size	Total Raised
Actio Biosciences	Series BJun 2025$66M Series ASep 2023$55M	$120M
Co-investors: Jason Fuller (Deerfield Management)
Rondo Therapeutics	Series AMar 2022$67M	$67M
Vineti	Series COct 2020$33M Series CFeb 2020$35M Series BApr 2018$34M	$100M
Co-investors: Mike Pellini (Section 32), Marc Benioff
Intrepida Bio	Series AOct 2019$10M	$10M
Dauntless Pharmaceuticals	Series AFeb 2017$25M	$37M
Co-investors: David Kabakoff (HealthQuest Capital)
Welltok	Series EOct 2016$34M Series DJan 2015$37M Series CFeb 2014$22M Series BApr 2013$19M	$240M
Co-investors: Blake Wu (New Enterprise Associates (NEA)), Kevin Spain (Emergence Capital), Mohamad Makhzoumi (New Enterprise Associates (NEA)), Lily Huang (New Enterprise Associates (NEA)), Sharon Stevenson (Okapi Venture Capital), Michael Greeley (Flare Capital Partners), Bruce Hallett (Miramar Ventures)
TESARO	Post Ipo EquityMar 2016$160M Series BJun 2011$100M	$320M
Co-investors: Beth Seidenberg (Westlake Village BioPartners), Scott Weiner (Amzak Health Investors), Sara Nayeem (Avoro Ventures)
Tizona Therapeutics	Series BMar 2016$43M	$43M
Co-investors: Jean George (Advanced Technology Ventures)